Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/109605
PIRA download icon_1.1View/Download Full Text
Title: Amelioration of non-alcoholic fatty liver disease by targeting adhesion G protein-coupled receptor F1 (Adgrf1)
Authors: Wu, M
Lo, TH 
Li, L
Sun, J
Deng, C 
Chan, KY 
Li, X 
Yeh, STY
Lee, JTH
Lui, PPY
Xu, A
Wong, CM 
Issue Date: 2023
Source: eLife, 2023, v. 12, e85131
Abstract: Background: Recent research has shown that the adhesion G protein-coupled receptor F1 (Adgrf1; also known as GPR110; PGR19; KPG_012; hGPCR36) is an oncogene. The evidence is mainly based on high expression of Adgrf1 in numerous cancer types, and knockdown Adgrf1 can reduce the cell migration, invasion, and proliferation. Adgrf1 is, however, mostly expressed in the liver of healthy individuals. The function of Adgrf1 in liver has not been revealed. Interestingly, expression level of hepatic Adgrf1 is dramatically decreased in obese subjects. Here, the research examined whether Adgrf1 has a role in liver metabolism.
Methods: We used recombinant adeno-associated virus-mediated gene delivery system, and antisense oligonucleotide was used to manipulate the hepatic Adgrf1 expression level in diet-induced obese mice to investigate the role of Adgrf1 in hepatic steatosis. The clinical relevance was examined using transcriptome profiling and archived biopsy specimens of liver tissues from non-alcoholic fatty liver disease (NAFLD) patients with different degree of fatty liver.
Results: The expression of Adgrf1 in the liver was directly correlated to fat content in the livers of both obese mice and NAFLD patients. Stearoyl-coA desaturase 1 (Scd1), a crucial enzyme in hepatic de novo lipogenesis, was identified as a downstream target of Adgrf1 by RNA-sequencing analysis. Treatment with the liver-specific Scd1 inhibitor MK8245 and specific shRNAs against Scd1 in primary hepatocytes improved the hepatic steatosis of Adgrf1-overexpressing mice and lipid profile of hepatocytes, respectively.
Conclusions: These results indicate Adgrf1 regulates hepatic lipid metabolism through controlling the expression of Scd1. Downregulation of Adgrf1 expression can potentially serve as a protective mechanism to stop the overaccumulation of fat in the liver in obese subjects. Overall, the above findings not only reveal a new mechanism regulating the progression of NAFLD, but also proposed a novel therapeutic approach to combat NAFLD by targeting Adgrf1.
Funding: This work was supported by the National Natural Science Foundation of China (81870586), Area of Excellence (AoE/M-707/18), and General Research Fund (15101520) to CMW, and the National Natural Science Foundation of China (82270941, 81974117) to SJ.
Publisher: eLife Sciences Publications Ltd.
Journal: eLife 
EISSN: 2050-084X
DOI: 10.7554/eLife.85131
Rights: Copyright Wu et al. This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use and redistribution provided that the original author and source are credited.
The following publication Wu, M., Lo, T.-H., Li, L., Sun, J., Deng, C., Chan, K.-Y., Li, X., Yeh, S. T.-Y., Lee, J. T. H., Lui, P. P. Y., Xu, A., & Wong, C.-M. (2023). Amelioration of non-alcoholic fatty liver disease by targeting adhesion G protein-coupled receptor F1 (Adgrf1). eLife, 12, e85131 is available at https://doi.org/10.7554/eLife.85131.
Appears in Collections:Journal/Magazine Article

Files in This Item:
File Description SizeFormat 
elife-85131-v2.pdf10.58 MBAdobe PDFView/Open
Open Access Information
Status open access
File Version Version of Record
Access
View full-text via PolyU eLinks SFX Query
Show full item record

Page views

4
Citations as of Nov 17, 2024

Downloads

8
Citations as of Nov 17, 2024

SCOPUSTM   
Citations

2
Citations as of Nov 21, 2024

WEB OF SCIENCETM
Citations

3
Citations as of Nov 21, 2024

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.